openPR Logo
Press release

Brain Metastases Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies Involved

08-17-2022 07:32 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Brain Metastases Pipeline

Brain Metastases Pipeline

As per DelveInsight's assessment, globally, nearly 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Brain Metastases therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA) and molecule types. Several of the therapies are in the advanced stages of clinical development expected to launch in the coming years.

"Brain Metastases Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Brain Metastases Therapeutics Market.

The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).

The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Download the sample pages:
https://www.delveinsight.com/report-store/brain-metastases-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Brain Metastases Pipeline Analysis
The report provides insights into:
• The report provides detailed insights about companies that are developing therapies in the Brain Metastases Market.
• It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Brain Metastases treatment.
• Brain Metastases key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Brain Metastases Drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Brain Metastases market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Request for Sample PDF:
https://www.delveinsight.com/report-store/brain-metastases-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Brain Metastases Therapeutics Analysis
There are approx. 50+ key companies which are developing therapies for Brain metastases. HUYA Bioscience has its drug candidates in the most advanced stage of clinical development.

Brain Metastases Therapies covered in the report include:
• HUYA Bioscience
• Genentech
• Kazia Therapeutics
• BioMimetix
• EpicentRx, Inc.
• Angiochem
• Medolution Ltd.
• Betta Pharmaceuticals Co., Ltd.
• Merck Sharp & Dohme LLC
• Jiangsu HengRui Medicine Co., Ltd.
• Bristol-Myers Squibb
• Pfizer
• Novartis Pharmaceuticals
• Daiichi Sankyo, Inc.
• Amgen
• 2-BBB Medicines
• Ipsen
• AstraZeneca
• Genentech
• ImmunoChem Therapeutics
• DEKK-TEC, Inc.
• Nascent Biotech
• Gilead Sciences
• Jiangsu Hansoh Pharmaceutical Co., Ltd.
• Surgimab
• Puma Biotechnology
• Quadriga Biosciences, Inc.
• Jubilant Therapeutics
• Denali Therapeutics Inc
• Jiangsu Simcere Pharmaceutical
• NUVATION BIO
• Novocure GmbH
• Affinia Therapeutics
• Specialised Therapeutics
• Precirix
• Ashvattha Therapeutics
And many others

Brain Metastases Therapies covered in the report include:
• HBI-8000 (HUYA Bioscience)
• Paxalisib (Genentech/ Kazia Therapeutics)
And many more

Request the Sample PDF to Get a more in-depth Assessment:
https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Brain Metastases Current Treatment Patterns
4. Brain Metastases - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Brain Metastases Late Stage Products (Phase-III)
7. Brain Metastases Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Brain Metastases Discontinued Products
13. Brain Metastases Product Profiles
14. Brain Metastases Key Companies
15. Brain Metastases Key Products
16. Dormant and Discontinued Products
17. Brain Metastases Unmet Needs
18. Brain Metastases Future Perspectives
19. Brain Metastases Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.

Request for the Sample PDF (to get a detailed understanding of the TOC, Tables, and Figures included in the report), at: https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Anuj Rawat
Email: info@delveinsight.com
https://www.delveinsight.com/
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Brain Metastases Pipeline Assessment: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies Involved here

News-ID: 2706563 • Views:

More Releases from DelveInsight Business Research

Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 12.80% by 2032, Evaluates DelveInsight
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates DelveInsight
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million by 2032 at a CAGR of 6.91% by 2032, Evaluates DelveInsight
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth. DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices

All 5 Releases


More Releases for Brain

Brain Training Apps Market Boosting the Brain: The Rise of Brain Training Apps a …
Brain Training Apps Market Assessment worth $ 44.43 Billion by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Training Apps Market- by App Type (Memory, Attention, Language, Executive Function, Visual/spatial, and Other App Types), User Type (Android, iOS and Other User Types), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031." Get a free sample copy of
Nutrient Survival Champions Brain Health During Alzheimer's & Brain Awareness Mo …
This June, Nutrient Survival is reminding people that nourishing your mind is as crucial as feeding your body, offering a revolutionary BrainCare® line. Reno, NV (June 5, 2024) - As June marks Alzheimer's & Brain Awareness Month, Nutrient Survival, veteran-led pioneer in nutritional innovation, stands at the forefront of promoting cognitive well-being with its revolutionary BrainCare® line and Brain Omega 3 Bar®. With alarming statistics highlighting the prevalence of brain-related ailments among
Brain Monitoring Device Market - Harnessing the Power of Neurotechnology: Brain …
Newark, New Castle, USA: The "Brain Monitoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Brain Monitoring Device Market: https://www.growthplusreports.com/report/brain-monitoring-device-market/7889 This latest report researches the industry structure,
Supercharge Your Brain: Revolutionary Brain Health Supplements for Improved Brai …
The global 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Brain Health Supplements industry. The current
Global Wearable Brain Devices Market Growth by 2030 - Advanced Brain Monitoring …
The research report based on the Global Wearable Brain Devices Industry offers the detailed study of each and every aspect coupled with the Wearable Brain Devices market. The report also analyzes all the strategic developments made in the Wearable Brain Devices sector. The research report offers detailed and accurate numerical data on costs, revenues, sales, profits, etc. The market report narrowly analyzes all the key growth factors that are considered
Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking. Official Online Store - https://www.allnutritionhub.com/get-retro-x-focus-nootropic How does the Retro X Focus Function? It is common knowledge that we must work out